参考文献/References:
[1]智信,陈晓,苏佳灿.苦参碱药理作用研究进展[J].成都中医药大学学报,2017,40(1):123. [2]韩华,曹苋恺,殷鑫.氧化苦参碱抗肿瘤作用机制的研究进展[J].现代中药研究与实践,2017,31(2):78. [3]张明发,沈雅琴.苦参碱类生物碱抗菌药理作用的研究进展[J].抗感染药学,2018,15(3):369-370. [4]Ying XJ,Jin B,Chen XW,et al.Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro[J].Biomed Res Int,2015(7):150390. [5]熊旋,李磊,王庆才.氧化苦参碱对肿瘤抑制作用的研究进展[J].海南医学,2018,29(8):1135-1136. [6]Zhang S,Zhang Y,Zhuang Y,et al.Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation [J].PLoS One,2014,7(10):e46853. [7]Chang C,SP Liu,CH Fang.Effects of matrine on the proliferation of HT29 human colon cancer cells and its antitumor mechanism[J].Oncology Letters,2015,6(3):699-704． [8]何星星,余伟,姚树坤,等.苦参碱诱导肝癌HepG2细胞自噬的作用与机制[J].南昌大学学报（医学版）2018,58(2):1-4. [9]Li Q,Lai Y,Wang C,et al.Matrine inhibits the proliferation,invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-kappaB signaling pathway[J].Oncol Rep,2016,35(1):375-381. [10]李琦,王玲玲,徐佳,等.苦参碱在抗肿瘤治疗中的研究进展[J].国际检验医学杂志,2017,38(4):500- 501. [11]邱海江,袁穗蓉,张柳.氧化苦参碱对视网膜母细胞瘤端粒酶逆转录活性影响[J].医药前沿,2015, 36(7):277-278. [12]史卫林,李坚,陆建保,等.苦参素对肺癌A549细胞的放疗增敏作用及其机制[J].山东医药,2015,55 (29):33-35. [13]韩华,曹苋恺,殷鑫,等.氧化苦参碱抗肿瘤作用机制的研究进展[J].现代中药研究与实践,2017,31(2):79-80. [14]徐春琳.氧化苦参碱通过miR-125B-STAT3途径抑制卵巢癌细胞增殖与侵袭的研究[D].河北医科大学，2015. [15]赵海亮,黄桂柳,黄赞松,等.苦参碱抑制人肝癌HepG2细胞增殖及其对VEGF、MMP-9 表达的影响[J].右江民族医学院学报,2016,38(1):1-5. [16]王财,王晓莉,常巧梅,等.苦参素对三维适形放射治疗中晚期肺癌疗效及血清VEGF、MMP-9水平的影响[J].青海医学院学报,2016,37(3):185-188. [17]Liu Y,Bi T,Wang Z,et al.Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway[J].Apoptosis,2016,21(12): 1398-1407. [18]Lin Y,Lin L,Jin Y,et al.Combination of Matrine and Sorafenib Decreases the Aggressive Phenotypes of Hepatocellular Carcinoma Cells[J].Chemotherapy,2014,60(2):112-118. [19]Wu D,Shao K,Sun J,et al.Matrine cooperates with all-trans retinoic acid on differentiation induction of all-trans retinoic acid-resistant acute promyelocytic leukemia cells(NB4-LR1):possible mechanisms[J].Planta Medica,2014,80(5):399-408. [20]刘晶晶，牟艳玲.苦参碱抗肿瘤作用机制的研究进展[J].中国药房，2017，28（19）：2707-2710.
相似文献/References:
[1]杨森果,毛大华,杨海松,等.E-cadherin与肿瘤侵袭、转移相关性研究进展[J].医学信息,2018,31(03):3.[doi:10.3969/j.issn.1006-1959.2018.04.002]
YANG Sen-guo,MAO Da-hua,YANG Hai-song,et al.Research Progress of the Correlation between E-cadherin and Tumor Invasion and Metastasis[J].Medical Information,2018,31(19):3.[doi:10.3969/j.issn.1006-1959.2018.04.002]
[2]江立基,李先明.碳酸酐酶Ⅸ在肿瘤中的研究进展[J].医学信息,2018,31(03):7.[doi:10.3969/j.issn.1006-1959.2018.03.003]
JIANG Li-ji,LI Xian-ming.Research Progress of Carbonic Anhydrase IX in Cancer[J].Medical Information,2018,31(19):7.[doi:10.3969/j.issn.1006-1959.2018.03.003]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(19):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]白 雪,邓 琦.血液系统肿瘤的细胞治疗研究进展[J].医学信息,2018,31(10):41.[doi:10.3969/j.issn.1006-1959.2018.10.013]
BAI Xue,DENG Qi.Advances in Cell Therapy for Blood System Tumor[J].Medical Information,2018,31(19):41.[doi:10.3969/j.issn.1006-1959.2018.10.013]
[5]李 轩,王子为,赵靖萱,等.肿瘤预后预测领域机器学习应用的文献计量与热点可视化分析[J].医学信息,2022,35(09):90.[doi:10.3969/j.issn.1006-1959.2022.09.023]
LI Xuan,WANG Zi-wei,ZHAO Jing-xuan,et al.Visualization Analysis on Bibliometrics and Hot Spots of Machine Learning Applications in the Field of Tumor Prognosis Prediction[J].Medical Information,2022,35(19):90.[doi:10.3969/j.issn.1006-1959.2022.09.023]
[6]王 静,刘 梅,焦菊凤.知-信-行健康教育模式对PICC置管肿瘤
患者自我护理能力的影响[J].医学信息,2018,31(11):170.[doi:10.3969/j.issn.1006-1959.2018.11.056]
WANG Jing,LIU Mei,JIAO Ju-feng.Effect of Knowledge-belief-behavioral Health Education Model on the Self-care Ability of Patients with Cancer in PICC Catheterization[J].Medical Information,2018,31(19):170.[doi:10.3969/j.issn.1006-1959.2018.11.056]
[7]史红娟,李群锋,赵 华,等.舒林酸抗肿瘤作用的研究进展[J].医学信息,2018,31(12):35.[doi:10.3969/j.issn.1006-1959.2018.12.012]
SHI Hong-juan,LI Qun-feng,ZHAO Hua,et al.Advances in Research on Anti-tumor Effect of Sulindac[J].Medical Information,2018,31(19):35.[doi:10.3969/j.issn.1006-1959.2018.12.012]
[8]庞小坤,韩 梅,江心灿,等.当归补血汤治疗肿瘤化疗不良反应随机对照临床试验的Meta分析[J].医学信息,2019,32(02):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
Pang Xiao-kun,Han Mei,Jiang Xin-can,et al.Meta-analysis of a Randomized Controlled Clinical Trial of Angelica Buxue Decoction in the Treatment of Adverse Reactions to Chemotherapy[J].Medical Information,2019,32(19):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
[9]张 慧,胡广越,殷 红.菌群干预与免疫治疗的研究进展[J].医学信息,2022,35(11):54.[doi:10.3969/j.issn.1006-1959.2022.11.016]
ZHAHG Hui,HU Guang-yue,YIN Hong.Research Progress in Microbial Intervention and Immunotherapy[J].Medical Information,2022,35(19):54.[doi:10.3969/j.issn.1006-1959.2022.11.016]
[10]缪继东.盐酸吗啡缓释片联合低剂量阿米替林治疗中重度癌性骨痛的疗效观察[J].医学信息,2018,31(21):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
MIAO Ji-dong.Effects of Morphine Hydrochloride Sustained-release Tablets Combined with Low Dose Amitriptyline in the Treatment of Moderate and Severe Cancer Bone Pain[J].Medical Information,2018,31(19):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]